阿斯特拉实验室发布了强的2026年第二季度收益,但高管们尽管前景乐观,但仍卖出了2768万美元的股票. Astera Labs posted strong Q2 2026 earnings, but executives sold $27.68 million in stock despite positive outlook.

2026年初,Astera实验室报告第二季度收入丰厚,EPS为58美元,收入为2.7558亿美元,比上一年增加91.8%。 In early 2026, Astera Labs reported strong second-quarter earnings, with $0.58 EPS and $270.58 million in revenue, up 91.8% year-over-year. 机构投资者增加了他们的利害关系,第一信托顾问LP将其持有量增加了140.4%,而Silvant资本管理公司获得了11 237个股份。 Institutional investors increased their stake, with First Trust Advisors LP boosting its holding by 140.4%, while Silvant Capital Management acquired 11,237 shares. 该公司价值212.3亿美元,项目为Q1 2026 EPS0.530至0.540美元。 The company, valued at $21.23 billion, projects Q1 2026 EPS of $0.530 to $0.540. 在过去90天里, 高管们出售了224 292股, 价值2 768万美元。 Despite a "Moderate Buy" consensus rating and a $195.89 target price, executives sold 224,292 shares worth $27.68 million in the past 90 days.